1: Srinivas NR. Interspecies scaling of excretory amounts using allometry - retrospective analysis with rifapentine, aztreonam, carumonam, pefloxacin, miloxacin, trovafloxacin, doripenem, imipenem, cefozopran, ceftazidime, linezolid for urinary excretion and rifapentine, cabotegravir, and dolutegravir for fecal excretion. Xenobiotica. 2016 Sep;46(9):784-92. doi: 10.3109/00498254.2015.1121554. PubMed PMID: 26711252.
2: Bulitta JB, Duffull SB, Landersdorfer CB, Kinzig M, Holzgrabe U, Stephan U, Drusano GL, Sörgel F. Comparison of the pharmacokinetics and pharmacodynamic profile of carumonam in cystic fibrosis patients and healthy volunteers. Diagn Microbiol Infect Dis. 2009 Oct;65(2):130-41. doi: 10.1016/j.diagmicrobio.2009.06.018. PubMed PMID: 19748423.
3: Imada A, Kondo M, Okonogi K, Yukishige K, Kuno M. In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic. Antimicrob Agents Chemother. 1985 May;27(5):821-7. PubMed PMID: 3874598; PubMed Central PMCID: PMC180159.
4: Konishi K, Suzuki H, Saruta T, Deguchi N, Fugono T. Pharmacokinetics of carumonam (AMA-1080) in patients with impaired renal function and in those undergoing hemodialysis. Antimicrob Agents Chemother. 1991 Jun;35(6):1048-52. PubMed PMID: 1929242; PubMed Central PMCID: PMC284284.
5: Barclay CA, Iribarren MA, Goldberg M, Traballi CA, Casellas JM. Comparative in vitro activity of carumonam (Ro 17-2301/AMA-1080), a new monobactam, and ceftriaxone against aerobic or facultative gram-negative isolates. Chemotherapy. 1987;33(3):165-71. PubMed PMID: 3595259.
6: Hoepelman AI, Bakker LJ, Verhoef J. Carumonam (Ro 17-2301; AMA-1080) compared with gentamicin for treatment of complicated urinary tract infections. Antimicrob Agents Chemother. 1988 Apr;32(4):473-6. PubMed PMID: 3377459; PubMed Central PMCID: PMC172204.
7: Jones RN, Barry AL, Thornsberry C, Fuchs PC, Packer RR. The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactam. Am J Clin Pathol. 1986 Nov;86(5):608-18. PubMed PMID: 3096130.
8: Le Noc P, Croize J, Le Noc D. [Comparative antibacterial activity of a new monobactam, carumonam (RO 17-2301, AMA 1080) on hospital bacteria resistant to beta lactams]. Pathol Biol (Paris). 1987 May;35(5):451-6. French. PubMed PMID: 3302846.
9: Yoshida K, Mitani M, Naeshiro I, Torii H, Tanayama S. Disposition of carumonam (AMA-1080/Ro 17-2301), a new N-sulfonated monocyclic beta-lactam, in rats and dogs. Antimicrob Agents Chemother. 1986 Jun;29(6):1017-24. PubMed PMID: 3729358; PubMed Central PMCID: PMC180494.
10: Angehrn P. Antibacterial properties of carumonam (Ro 17-2301, AMA-1080), a new sulfonated monocyclic beta-lactam antibiotic. Chemotherapy. 1985;31(6):440-50. PubMed PMID: 3935396.
11: Hohl P, von Graevenitz A, Zollinger-Iten J. In vitro activity of carumonam (Ro 17-2301; AMA-1080) versus enteropathogenic and nonfermentative gram-negative rods and Legionella pneumophila. Antimicrob Agents Chemother. 1988 Oct;32(10):1593-4. PubMed PMID: 3190188; PubMed Central PMCID: PMC175927.
12: Kita Y, Fugono T, Imada A. Comparative pharmacokinetics of carumonam and aztreonam in mice, rats, rabbits, dogs, and cynomolgus monkeys. Antimicrob Agents Chemother. 1986 Jan;29(1):127-34. PubMed PMID: 3729325; PubMed Central PMCID: PMC180377.
13: Matsuda K, Hamana Y, Inoue M, Mitsuhashi S. In-vitro antibacterial activity of AMA-1080. J Antimicrob Chemother. 1985 Nov;16(5):539-47. PubMed PMID: 3878360.
14: Then RL, Kohl I. Affinity of carumonam for penicillin-binding proteins. Chemotherapy. 1985;31(4):246-54. PubMed PMID: 3928279.
15: Weidekamm E, Stoeckel K, Egger HJ, Ziegler WH. Single-dose pharmacokinetics of Ro 17-2301 (AMA-1080), a monocyclic beta-lactam, in humans. Antimicrob Agents Chemother. 1984 Dec;26(6):898-902. PubMed PMID: 6395801; PubMed Central PMCID: PMC180046.